AN1 0.00% 0.8¢ anagenics limited

I am not sure, pharma. It seems to me that treating patients...

  1. 551 Posts.
    lightbulb Created with Sketch. 173
    I am not sure, pharma.

    It seems to me that treating patients with the midkine protein has potential in some indications, whereas inhibiting it is a strategy for other indications.

    I was hoping that someone with the right background might find the time to comment. There used to be a user here with a medical background who commented rarely, but I haven't read from her or him in a while.
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.